Albany Molecular Research Inc (AMRI) Financial Statements (2024 and earlier)

Company Profile

Business Address 21 CORPORATE CIRCLE
ALBANY, NY 12203-5154
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2017
MRQ
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 52,00049,34346,995175,92823,293
Cash and cash equivalents 52,00049,34346,995175,92823,293
Restricted cash and investments 2362,9664,052  
Receivables 146,821115,84671,64452,21642,496
Inventory, net of allowances, customer advances and progress billings 167,11189,23149,88031,99128,216
Inventory 167,11189,23149,88031,99128,216
Prepaid expense and other current assets7,337
Other undisclosed current assets 26,74322,85918,44118,88412,082
Total current assets: 392,911280,245191,012279,019113,424
Noncurrent Assets
Property, plant and equipment 364,806209,508165,475127,775135,519
Long-term investments and receivables  956956956956
Long-term investments  956956956956
Intangible assets, net (including goodwill) 396,430289,67594,3263,0423,065
Goodwill 231,256169,47161,778  
Intangible assets, net (excluding goodwill) 165,174120,20432,5483,0423,065
Derivative instruments and hedges 51,00376,39358,92822,654 
Restricted cash and investments    3,8104,524
Other noncurrent assets 3,9943,4045,3286,921
Prepaid expense and other noncurrent assets1,854
Other undisclosed noncurrent assets 5045,3863,9281,0913,520
Total noncurrent assets: 816,737585,322328,941166,249149,438
TOTAL ASSETS: 1,209,648865,567519,953445,268262,862
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 111,14760,89032,16024,17918,194
Taxes payable 2,826 3503,9541,148
Employee-related liabilities 11,7437,8974,235  
Other undisclosed accounts payable and accrued liabilities 96,57852,99327,57520,22517,046
Debt 36,43215,5914471,846776
Estimated litigation liability   3271,3512,717
Deferred revenue and credits 13,37014,71811,1716,5887,365
Other undisclosed current liabilities 14,5697,8974,5859,9386,934
Total current liabilities: 175,51899,09648,69043,90235,986
Noncurrent Liabilities
Long-term debt and lease obligation 604,476373,692159,980123,1357,227
Long-term debt, excluding current maturities 604,476373,692159,980123,1357,227
Liabilities, other than long-term debt 130,67289,15169,46132,52713,508
Deferred revenue and credits    1,9262,857
Pension and other postretirement defined benefit plans, liabilities6,0598,691
Accounts payable and accrued liabilities 3,7692,956   
Deferred tax liabilities, net 40,058  631753
Liability, pension and other postretirement and postemployment benefits 18,6156,9098,167
Other liabilities 17,2272,8932,3661,2571,207
Derivative instruments and hedges, liabilities 51,00376,39358,92822,654 
Other undisclosed noncurrent liabilities  16,405   
Total noncurrent liabilities: 735,148479,248229,441155,66220,735
Total liabilities: 910,666578,344278,131199,56456,721
Equity
Equity, attributable to parent 298,982287,223241,822245,704206,141
Common stock 485411381370363
Treasury stock, value (69,429)(68,455)(67,631)(67,052)(66,888)
Additional paid in capital 400,496296,337243,874235,806207,784
Accumulated other comprehensive loss (39,730)(18,401)(14,434)(11,277)(10,295)
Retained earnings 7,16077,33179,63287,85775,177
Total equity: 298,982287,223241,822245,704206,141
TOTAL LIABILITIES AND EQUITY: 1,209,648865,567519,953445,268262,862

Income Statement (P&L) ($ in thousands)

6/30/2017
TTM
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
 570,450402,356276,571246,575226,686
Cost of revenue (447,901)(296,081)(210,814)(174,690)(168,064)
Cost of goods and services sold (437,649)(296,081)(210,814)(174,690)(168,064)
Gross profit: 122,549106,27565,75771,88558,622
Operating expenses (141,308)(92,626)(80,363)(68,102)(72,432)
Other undisclosed operating income   20,33016,39214,513
Operating income (loss): (18,759)13,6495,72420,175703
Nonoperating income (expense) (1,277)2,234(966)783(121)
Loss, foreign currency transaction, before tax   (734)  
Other nonoperating income (expense) (1,277)2,220(235)772(130)
Interest and debt expense (39,923)(19,352)(10,960)(1,255)(463)
Other undisclosed income from continuing operations before equity method investments, income taxes   734  
Income (loss) from continuing operations before income taxes: (59,959)(3,469)(5,468)19,703119
Income tax expense (benefit) (10,212)1,1682,190(7,023)(3,896)
Income (loss) from continuing operations: (70,171)(2,301)(3,278)12,680(3,777)
Income (loss) before gain (loss) on sale of properties: (70,171)(2,301)(3,278)12,680(3,777)
Net income (loss) available to common stockholders, diluted: (70,171)(2,301)(3,278)12,680(3,777)

Comprehensive Income ($ in thousands)

6/30/2017
TTM
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net income (loss): (70,171)(2,301)(3,278)12,680(3,777)
Other comprehensive income (loss) (21,329)(3,967)(3,157)(982)1,771
Comprehensive income (loss), net of tax, attributable to parent: (91,500)(6,268)(6,435)11,698(2,006)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: